<- Go Home
Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Market Cap
$234.0M
Volume
206.0K
Cash and Equivalents
$9.5M
EBITDA
-$1.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$45.6M
Profit Margin
34.87%
52 Week High
$8.90
52 Week Low
$3.68
Dividend
N/A
Price / Book Value
15.13
Price / Earnings
-11.44
Price / Tangible Book Value
-88.80
Enterprise Value
$400.2M
Enterprise Value / EBITDA
-575.82
Operating Income
-$9.9M
Return on Equity
29.58%
Return on Assets
-2.47
Cash and Short Term Investments
$9.5M
Debt
$131.3M
Equity
$59.8M
Revenue
$130.9M
Unlevered FCF
-$9.6M
Sector
Life Sciences Tools and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium